Drug recall · January 26, 2022
Clobazam Oral Suspension 2.5 mg/mL recall
Why: Failed Stability Specifications
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
- Lots / codes
Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023
- Quantity
- 18,456 bottles
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- Nationwide within the United States including Puerto Rico
- Initiated
- January 7, 2022 · Voluntary: Firm initiated
- Classified
- January 18, 2022
- Reported
- January 26, 2022
- Ended
- December 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobazam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.